If you buy through a BGR link, we may earn an affiliate commission, helping support our expert product labs. Getting addicted, no pun intended, to an animated conspiracy thriller from Adult Swim ...

This was data back when Musk referenced it last month: Musk particularly praised the highway mileage of 723 miles between disengagement, which was a big jump over Tesla FSD v12, but we noted that ...

Bearish flow noted in GSK (GSK) Pharma with 1,131 puts trading, or 2x expected. Most active are Mar-25 33 puts and Jan-26 35 puts, with total volume in those strikes near 730 contracts.

(RTTNews) - Astellas Pharma Inc. (ALPMY) Wednesday announced the submission of a New Drug Application or NDA in Japan for Conditional Approval of Avacincaptad Pegol intravitreal solution or ACP ...

Perform material- and labor-effective extrusion with Thermo Scientific™ Pharma 11 Twin-screw Extruder, which requires only a small amount of active pharmaceutical ingredient, operating at ...

LabVantage Pharma is the only pre-configured and pre-validated pharmaceutical LIMS in the world. This greatly lowers the deployment cost (85%) and time (75%) compared to a traditional LIMS ...

Now, Republicans at the federal level find themselves in a similar position to deliver on long-promised reforms — starting with reining in Big Pharma. This crisis is unique to the United States.

Analysts casting their eyes forward to 2022 see big pharma maintaining its position in the sector, protected by vast war chests and ready to pounce on any newcomer that shows promise. In the ...

Needless to say, a gap between company and analyst expectations this big is almost always based on a big, unusual factor. In this case, that factor is the company's decision to pause shipments of ...

(NEXSTAR) — For years, there has been a subset of football fans that claims the NFL is scripted. They even claim to collect “proof” outcomes are rigged, like bad referee calls or player ...

The last few years have been marked by many big pharma companies opting to move away from diversification and towards more focused operations. Ben Hargreaves explores what is driving this ...